Blend Labs, Inc. (NYSE:BLND) Insider Brian Kneafsey Sells 30,000 Shares of Stock

Blend Labs, Inc. (NYSE:BLNDGet Free Report) insider Brian Kneafsey sold 30,000 shares of the business’s stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $5.12, for a total value of $153,600.00. Following the completion of the transaction, the insider now directly owns 937,439 shares of the company’s stock, valued at approximately $4,799,687.68. This trade represents a 3.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Blend Labs Price Performance

BLND stock opened at $5.08 on Friday. The firm has a 50-day simple moving average of $4.30 and a 200-day simple moving average of $3.53. Blend Labs, Inc. has a 52 week low of $1.85 and a 52 week high of $5.53.

Hedge Funds Weigh In On Blend Labs

A number of institutional investors have recently added to or reduced their stakes in the stock. Dark Forest Capital Management LP purchased a new stake in shares of Blend Labs in the 2nd quarter valued at approximately $31,000. Xponance Inc. acquired a new position in Blend Labs during the second quarter worth $35,000. Virtu Financial LLC purchased a new position in shares of Blend Labs during the third quarter worth $63,000. RiverPark Advisors LLC acquired a new stake in shares of Blend Labs in the third quarter valued at $77,000. Finally, FMR LLC raised its holdings in shares of Blend Labs by 15.8% in the 3rd quarter. FMR LLC now owns 26,148 shares of the company’s stock valued at $98,000 after buying an additional 3,576 shares during the period. Hedge funds and other institutional investors own 52.56% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. UBS Group boosted their price target on Blend Labs from $3.00 to $4.00 and gave the company a “neutral” rating in a report on Wednesday, October 23rd. Wells Fargo & Company increased their price target on shares of Blend Labs from $4.50 to $6.50 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Keefe, Bruyette & Woods lifted their price objective on shares of Blend Labs from $3.25 to $3.85 and gave the company a “market perform” rating in a report on Thursday, November 7th. Canaccord Genuity Group increased their target price on shares of Blend Labs from $4.75 to $5.75 and gave the stock a “buy” rating in a research note on Thursday, November 7th. Finally, The Goldman Sachs Group raised their target price on Blend Labs from $3.40 to $3.90 and gave the company a “buy” rating in a research report on Thursday, November 7th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $4.79.

Read Our Latest Report on BLND

Blend Labs Company Profile

(Get Free Report)

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.

Recommended Stories

Insider Buying and Selling by Quarter for Blend Labs (NYSE:BLND)

Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.